It’s not just Wall Street or Silicon Valley. The pressure to maintain productivity, the onset of burnout syndrome, and the drive to enhance creativity are all reasons why substance use continues to persist in the workplace
After half-a-century of prohibition, the United States is about to legalize psilocybin and MDMA for clinical use, to treat people suffering from post-traumatic stress disorder or terminal cancer. Scientists, patients, clandestine therapists and war veterans speak with EL PAÍS about the bright spots and shadows of this rebirth
The author of ‘How to Change Your Mind,’ a key text in the resurgence of scientific research on psychoactive substances, worries about the creation of a ‘bubble’
Beyond the famous New Year’s Eve parties and the stories and controversies that surround them, Europe’s ‘free party’ movement has an ethics and a history that traces back to its origins in the 1980s
Also known as ‘tusi’ and ‘tucibi’, in Spain it sells for about 100 dollars per gram and is a mixture of cheaper substances such as ketamine and ecstasy
Just hours before Balwani was supposed to surrender to authorities, his lawyer filed documents notifying U.S. District Judge Edward Davila that he wouldn’t be doing so
Treatments have confirmed the therapeutic efficacy of psychoactive substances such as LSD and THC… but the debate about their relationship with consciousness has only just begun